Atrial Natriuretic Peptide (ANP), rat: Mechanism & Research Uses

Executive Summary: Atrial Natriuretic Peptide (ANP; C49H84N20O15S), rat is a 28-amino acid peptide hormone secreted by atrial myocytes in response to cardiovascular stimuli. It directly induces vasodilation and promotes natriuresis, facilitating blood pressure homeostasis and fluid balance (product info). ANP is stable as a solid at -20°C, highly soluble in DMSO and water, and provided by APExBIO at >95% purity, enabling consistent experimental results. Its validated use spans cardiovascular, renal, and metabolic research, with best practices documented in several peer-reviewed and product-based references. Misconceptions regarding cross-domain efficacy or storage conditions persist, underscoring the need for protocol adherence and evidence-based application.

Biological Rationale

Atrial Natriuretic Peptide (ANP) is a key endogenous regulator of cardiovascular homeostasis. Synthesized and secreted by atrial myocytes, ANP responds to atrial stretch, angiotensin II, and sympathetic activation (APExBIO product page). The peptide hormone is evolutionarily conserved and central to natriuresis, diuresis, and systemic blood pressure regulation. Unlike related natriuretic peptides, ANP’s primary action is acute modulation of vascular tone and renal sodium excretion. Its sequence, H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH, defines its high receptor specificity and biological activity. For a detailed exploration of ANP’s classic and emergent signaling roles, see this advanced mechanistic review, which this article extends by providing updated storage, solubility, and purity benchmarks.

Mechanism of Action of Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat

Upon cardiac release, ANP binds natriuretic peptide receptor-A (NPR-A), triggering cyclic GMP (cGMP) production in target tissues. This cascade results in smooth muscle relaxation (vasodilation), enhanced glomerular filtration, and increased sodium excretion. The downstream effect is a reduction in blood volume and systemic arterial pressure, supporting homeostatic equilibrium. ANP additionally promotes lipolysis and modulates adipose tissue metabolism. Its rapid, receptor-mediated mechanism is foundational for studies of acute and chronic cardiovascular adaptation. For scenario-driven protocol guidance on incorporating high-purity ANP in metabolic and renal assays, see this workflow guide, which this article updates with new purity and solubility data.

Evidence & Benchmarks

• ANP is a 28-residue peptide hormone (H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH) with a molecular weight of 1225.38 Da and chemical formula C49H84N20O15S (product info).
• Purity is confirmed at 95.92% by HPLC and mass spectrometry, supporting reproducibility in cardiovascular research workflows (APExBIO).
• Solubility is ≥122.5 mg/mL in DMSO and ≥43.5 mg/mL in water, but ANP is insoluble in ethanol (product info).
• ANP induces rapid vasodilation and natriuresis via cGMP signaling, reducing blood pressure and extracellular fluid volume (mechanism review).
• APExBIO’s ANP (rat) is validated for cardiovascular, renal, and adipose metabolism research, enabling quantitative studies in blood pressure homeostasis (protocol guide).

Applications, Limits & Misconceptions

ANP (C49H84N20O15S), rat is widely used for probing natriuresis mechanisms, hypertension models, and metabolic regulation in both in vivo and in vitro systems. It is a tool of choice for high-precision studies of blood pressure homeostasis, renal physiology, and adipose tissue signaling. The reagent’s high purity and batch-to-batch consistency support robust endpoint measurements. For translational applications, ANP is critical in evaluating therapeutic strategies for cardiovascular disease and fluid imbalance states. However, its effectiveness is limited to systems expressing functional NPR-A receptors and may not extend to non-mammalian models lacking this pathway. For a discussion of validated workflow parameters and pitfalls, see this benchmarking article, which is clarified here with newer storage and solubility protocols.

Common Pitfalls or Misconceptions

• ANP is not stable for extended periods in solution; long-term storage should be as a solid at -20°C (product info).
• The peptide is insoluble in ethanol, and attempts to dissolve in ethanol will fail or result in precipitation.
• Use of ANP outside mammalian systems with functional NPR-A receptors can yield false negative results.
• Assuming all natriuretic peptides have equivalent receptor specificity or potency is incorrect; ANP’s effects are distinct from BNP and CNP (mechanism review).
• Protocol deviations, such as improper buffer or pH, can reduce activity and confound assay interpretation.

Workflow Integration & Parameters

• Reconstitution: Dissolve ANP at ≥122.5 mg/mL in DMSO or ≥43.5 mg/mL in water for stock solutions; avoid ethanol.
• Storage: Store lyophilized ANP at -20°C. Use freshly prepared solutions and avoid repeated freeze-thaw cycles.
• Assay Controls: Include vehicle-only and NPR-A antagonist groups in functional studies.
• Dosing: Typical working concentrations in cellular assays range from 10 nM to 1 μM, optimized per experimental need.
• Shipping: Product is shipped with blue ice to maintain stability (product info).

Conclusion & Outlook

ANP (C49H84N20O15S), rat, remains a core cardiovascular research peptide, offering high purity and validated performance for mechanistic, pharmacological, and translational studies. Its well-defined solubility, storage, and functional benchmarks support reproducibility in blood pressure homeostasis and fluid balance research. Future directions include leveraging ANP’s established mechanisms for drug discovery and precision modeling of cardiovascular and renal disorders, as outlined in both peer-reviewed and product-based guidance (APExBIO).